22 May 2013
Keywords: pfizer, co-market, boehringer, ingelheim, copd, drug, blockbuster
Article | 12 April 2001
Boehringer Ingelheim has become the latest company to strike a deal withPfizer and gain access to the latter's undoubted marketing ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 April 2001
11 April 2001
21 May 2013
© 2013 thepharmaletter.com